EUVIMEDEUVIMED entdecken
Crossref

Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold

Eric P Gillis iD, Kyle Parcella iD, Michael Bowsher, James H Cook, Christiana Iwuagwu, B Narasimhulu Naidu iD, Manoj Patel, Kevin Peese iD, Haichang Huang, Lourdes Valera, Chunfu Wang, Kasia Kieltyka und 17 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Eric P Gillis und 28 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Chemistry, ViiV Healthcare, Branford, Connecticut 06405, United States. Hauptthemen laut MEDLINE: HIV-1, Anti-HIV Agents, HIV Infections. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-acting (LA) human immunodeficiency virus-1 (HIV-1) antiretroviral therapy characterized by a ≥1 month dosing interval offers significant advantages over daily oral therapy. However, the criteria for compounds that enter clinical development are high. Exceptional potency and low plasma clearance are required to meet dose size requirements; excellent chemical stability and/or crystalline form stability is required to meet formulation requirements, and new antivirals in HIV-1 therapy need to be largely free of side effects and drug-drug interactions. In view of these challenges, the discovery that capsid inhibitors comprising a quinazolinone core tolerate a wide range of structural modifications while maintaining picomolar potency against HIV-1 infection in vitro, are assembled efficiently in a multi-component reaction, and can be isolated in a stereochemically pure form is reported herein. The detailed characterization of a prototypical compound, GSK878, is presented, including an X-ray co-crystal structure and subcutaneous and intramuscular pharmacokinetic data in rats and dogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Anti-HIV AgentsHIV InfectionsHumansRatsAnimalsDogsCapsidCapsid ProteinsQuinazolinones

Substanzen

4-hydroxyquinazolineCapsid ProteinsQuinazolinonesAnti-HIV Agents

Autor:innen und Institutionen

  • Discovery Chemistry, ViiV Healthcare, Branford, Connecticut 06405, United States.
  • Discovery Biology, ViiV Healthcare, Branford, Connecticut 06405, United States.
  • Discovery Pharmaceutics, DMPK and Toxicology, ViiV Healthcare, Branford, Connecticut 06405, United States.
  • Molecular Design, GSK, Collegeville, Pennsylvania 19426, United States.
  • Protein Cellular and Structural Sciences, GSK, Collegeville, Pennsylvania 19426, United States.
  • Small Molecule Drug Discovery, Bristol Myers Squibb Research and Early Development, Princeton, New Jersey 08543, United States.

ORCID-Profile: Eric P Gillis, Kyle Parcella, B Narasimhulu Naidu, Kevin Peese, Nicholas A Meanwell

Zitieren

APA

Gillis, E. P., Parcella, K., Bowsher, M., Cook, J. H., Iwuagwu, C., Naidu, B. N., Patel, M., Peese, K., Huang, H., Valera, L., Wang, C., Kieltyka, K., Parker, D. D., Simmermacher, J., Arnoult, E., Nolte, R. T., Wang, L., Bender, J. A., Frennesson, D. B., …, & Fridell, R. (2023). Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01732

Vancouver

Gillis EP, Parcella K, Bowsher M, Cook JH, Iwuagwu C, Naidu BN, et al. Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01732

BibTeX
@article{Gillis2023,
  author = {Gillis, Eric P and Parcella, Kyle and Bowsher, Michael and Cook, James H and Iwuagwu, Christiana and Naidu, B Narasimhulu and Patel, Manoj and Peese, Kevin and Huang, Haichang and Valera, Lourdes and Wang, Chunfu and Kieltyka, Kasia and Parker, Dawn D and Simmermacher, Jean and Arnoult, Eric and Nolte, Robert T and Wang, Liping and Bender, John A and Frennesson, David B and Saulnier, Mark and Wang, Alan Xiangdong and Meanwell, Nicholas A and Belema, Makonen and Hanumegowda, Umesh and Jenkins, Susan and Krystal, Mark and Kadow, John F and Cockett, Mark and Fridell, Robert},
  title = {Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01732}
}
Kostenlos starten →